Chelsea McLean

10PUBLICATIONS
84CO-AUTHORS
Environmental epidemiologyInnate immunityModels of care and place of birthEpidemiological methodsPanel data analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 26, 2026
Correction: Leroux-Roels et al. Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study. Vaccines 2026, 14, 146.

|Apr 13, 2026
A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study.

Nina Hertoghs, Chan Tang, Vitalija van Paassen

|Feb 26, 2026
Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study.

Isabel Leroux-Roels, Tracey A Day, Sofie Deleu

|Sep 08, 2025
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial.

Julien Nyombayire, Rosine Ingabire, Amelia Mazzei

|Apr 02, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Thembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah

|Aug 29, 2024
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo.

Edward Man-Lik Choi, Kambale Kasonia, Hugo Kavunga-Membo

Pageof 2

Frequent Collaborators

2 joint publications

Salo N Ooft

2 joint publications

Michal Sarnecki

2 joint publications

Isabel Leroux-Roels

2 joint publications

Keira A Cohen